China Attracts Global Patients With Advanced Care
Foreign patients are increasingly traveling to China in 2024 to receive advanced treatments such as CAR-T therapy, proton therapy, and a Chinese-developed gene-editing drug. Shanghai hospitals report growing international volumes — Ruijin's international outpatient unit logged about 150,000 visits last year and Shanghai's public hospitals exceeded 300,000 international visits in H1 2024 — signaling rising cross-border referrals for complex care.
Key Points
- 1Report documents rising foreign patient inflows to China for complex care like CAR-T and proton therapy.
- 2Shows China combines clinical expertise, affordability, and shorter waits, attracting complex-case referrals internationally.
- 3Suggests hospitals and practitioners pursue cross-border collaborations, referral pathways, and specialized service development.
Scoring Rationale
Strong coverage of a growing medical-tourism trend with official hospital data, limited independent verification and modest analytical depth.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems
